Peripheral nociceptor receptors

Peripheral nociceptor receptors comprise a heterogeneous class of proteins expressed on the peripheral terminals of nociceptive sensory neurons, which are specialized to detect potentially tissue-damaging stimuli (StatPearls, 2024; NIH, 2017). These receptors include various ion channels and G protein-coupled receptors (GPCRs) that respond to thermal, mechanical, and chemical triggers (Wikipedia, 2024; Pitt.edu, 2024). Prominent examples include the transient receptor potential vanilloid 1 (TRPV1) channel, which detects noxious heat and capsaicin, and voltage-gated sodium channels like Nav1.7 and Nav1.8, which are essential for the generation and propagation of pain-related action potentials (NIH, 2017; Dovepress, 2022). In conditions of chronic pain or inflammation, these receptors often undergo sensitization, lowering the threshold for activation and contributing to persistent pain states (NIH, 2022; ResearchGate, 2021). Pharmacological modulation of these targets aims to reduce pain by inhibiting receptor activity or desensitizing the nerve endings (NIH, 2017). Current and emerging therapies include local anesthetics like lidocaine, selective ion channel blockers such as suzetrigine, and monoclonal antibodies like tanezumab that target associated growth factors (NIH, 2017; ResearchGate, 2022).

Other names

Nociceptive receptorsPain receptorsPeripheral pain transducersNociceptor ion channels and receptors

Drugs targeting peripheral nociceptor receptors typically act as antagonists or inhibitors to block the transduction or transmission of pain signals, or as agonists (like capsaicin) to induce long-term desensitization of the nociceptive terminal.